Published Date: 26 Apr 2023
The majority of people are familiar with rheumatoid arthritis and osteoarthritis. The new kid on the block, however, is psoriatic arthritis. Find out more about the signs, causes, and treatments of psoriatic arthritis by reading on.
Read Full NewsAmong 117 patients, breath-hold ventilation did not improve strict diagnostic yield vs conventional (86.8% vs 92.2%) in robotic bronchoscopy.
An epileptologist at Cleveland Clinic discussed findings from a recently published study of lifestyle interventions in epilepsy and why these approaches should complement rather than replace antiseizure medications.
Biopsy Scarring and Pegcetacoplan Response in C3G, With Carla Nester, MD
1.
Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?
2.
Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma
3.
FDA Approves Camizestrant for ESR1-Mutated Breast Cancer
4.
In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.
5.
A Possible Novel CAR-T Treatment for High-Risk R/R Follicular Lymphoma May Be Liso-Cel.
1.
A Review of Cancer Treatment Evolution Towards Stem Cells and Gene Therapy
2.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
3.
Case Study: Genomic Medicine in Precision Oncology
4.
Cancer Enhancer Rewiring and Tumor Cell Identity
5.
Risk Assessment of Iron Overload in Repeated Transfusion
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
2.
Chemotherapy: What to Expect
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation